Showing results (1-10 of 1,558) with videos related to
Sort By:
Pageof 156
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trialsMabel K Yan, Nikki R Adler, Natalie Heriot, et al.Asia-Pacific Journal of Clinical Oncology|March 13, 2021
Conventional supportive cancer care services in Australia: A national service mapping study (The CIA study)Elizabeth P Pinkham, Laisa Teleni, Jodie L Nixon, et al.Asia-Pacific Journal of Clinical Oncology|November 15, 2018
Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanomaSagun Parakh, Manreet Randhawa, Bella Nguyen, et al.Asia-Pacific Journal of Clinical Oncology|April 3, 2019
A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangementDaijiro Harada, Toshiyuki Kozuki, Naoyuki Nogami, et al.Asia-Pacific Journal of Clinical Oncology|March 15, 2019
Patterns of care for stage III non-small cell lung cancer in AustraliaPhillip Parente, Bryan A Chan, Brett G M Hughes, et al.Asia-Pacific Journal of Clinical Oncology|February 22, 2019
Allium vegetables are associated with reduced risk of colorectal cancer: A hospital-based matched case-control study in ChinaXin Wu, Jing Shi, Wan-Xia Fang, et al.Asia-Pacific Journal of Clinical Oncology|August 23, 2019
Radiotherapy for metastatic spinal cord compression; can the Rades score predict survival?Peter Kerstens, Ma Yi, Melissa JamesAsia-Pacific Journal of Clinical Oncology|September 12, 2019
Compliance with multidisciplinary team meeting management recommendationsAmali Samarasinghe, Arlene Chan, Diana Hastrich, et al.Asia-Pacific Journal of Clinical Oncology|January 27, 2021
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 ConsortiumToshio Shimizu, Dong-Wan Kim, Herbert H Loong, et al.Asia-Pacific Journal of Clinical Oncology|December 15, 2021
Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and IndiaSherene Loi, Christos S Karapetis, Nicole McCarthy, et al.Pageof 156